Psychedelic Therapy: Problems and Promises | Mental Health Professional Webinar

The psychedelic medicine field currently works in areas including depression, anxiety, and PTSD. Learn about the existing treatment options and the scientific, clinical and regulatory challenges in the field.
ADAA is proud to offer resources for mental health professionals. Find additional tools and information:
- Visit the ADAA website: adaa.org/professionals
- View upcoming professional webinars and events: adaa.org/calendar
- Subscribe to ADAA’s bi-weekly professional newsletter: adaa.informz.net/adaa/pages/I...
- The Anxiety and Depression Association of America (ADAA), a non-profit organization, leads in education, training, and research for anxiety disorders, depression, PTSD, OCD, and co-occurring disorders. ADAA also provides free evidence-based mental health information and resources to the public.
Chapters:
0:00 Introduction
4:23 Receptors and Psychedelics
12:42 Pivotal Mental States
13:22 Models of Psychedelic Therapy
22:15 Canalization
26:25 Psychedlics Impact on the Brain
46:55 Panel Discussion

[@tw9472]

In regard to myealination and antiinflammatory activities: Are there any possible benefits of psylocibin, DMT or similar psychodelics to people suffering from multiple sclerosis (MS)? The disease is often associated with depression, demyelination and inflammation also responsible for chronic fatigue. Cannabis (THC/CBD) has been long approved for MS treatment, what about the serotonin agonists?